chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swelling of lymph nodes at left side of collar bone, headache, body aches.; Swelling of lymph nodes at left side of collar bone, headache, body aches.; Swelling of lymph nodes at left side of collar bone, headache, body aches.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25May2021 15:15 (Lot number: EW0168) at the age of 27 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (lot number= EW0167, dose number=1, vaccine location=Left arm), administration date: 04May2021, when the patient was 27 years old, for COVID-19 Immunization. The following information was reported: LYMPHADENOPATHY (non-serious), HEADACHE (non-serious), PAIN (non-serious) all with onset 26May2021, outcome "not recovered" and all described as "Swelling of lymph nodes at left side of collar bone, headache, body aches.". Therapeutic measures were not taken as a result of lymphadenopathy, headache, pain.  Additional information- It was reported that patient administer vaccine at pharmacy drug store. The other medications patient received within 2 weeks of vaccination was Birth Control.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.Prior to vaccination,  the patient was not diagnosed with COVID-19 and Since the vaccination,the patient had not  been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Within 48 to 72 hours post 2nd dose of vax, the pt developed angioedema and a generalized rash. The pt recovered within 3-5 days. The reporter indicated that this event is definitely related to IZ. This event is considered medically important.
01/05/2022: Event occurred after 2nd vaccine. 55 y/o female with a PMH of COPD, asthma, HTN, left pneumothorax and right breast cancer who presents to the ED for chest pain, described as stabbing as well as on and off body aches and nausea vomiting.  As well as coughing. Been going on for the past two weeks and usually starts in the morning occasionally waking her up from sleep. Pt states that the pain has been about the same for the past two weeks, but she did develop a cough yesterday.   Pt also denies previous PE, DVT or any current nausea, vomiting, headache, changes in vision or hearing, abdominal pain, calf pain, diarrhea or blood in stool, dysuria or hematuria. Pt denies any known COVID positive or other sick contacts.
BLURRED VISION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced blurred vision. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blurred vision. This report was non-serious.; Sender's Comments: V0 Medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
36 hours after Pediarix, Hib, Prevnar, mother (an Emergency physician) noted grimacing and gasping type behavior-lasting several hrs. By next AM infant was fine. Similar reaction occurred with Rabies vaccine age 6-10 weeks-5 doses.
body pain; Can hardly move comfortably; This case was reported by a consumer via interactive digital media and described the occurrence of general body pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced general body pain and mobility decreased. On an unknown date, the outcome of the general body pain and mobility decreased were recovered/resolved.   It was unknown if the reporter considered the general body pain and mobility decreased to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR155404   Additional Information: GSK Receipt Date: 26-OCT-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. Patient took first dose it only lasted 1 day. By first dose his/her body had body aches and pain patient could hardly move around comfortably. Additional supportive information: For tolerance to the 2nd dose refer case US2022AMR155404.; Sender's Comments:  US-GSK-US2022AMR155404:Same reporter
The same day as vaccine second booster acerbated pain in shoulder. Next day went ER diagnosed with Frozen shoulder, medicine prescribed were  methocarbamol, naproxen, Voltaren. EKG done at ER due to chest pain. Difficulty sleeping due to pain.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  EPILEPSY, UNSPECIFIED ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXIA
This case was reported by a consumer and described the occurrence of soreness (generalized) in a 39-year-old female subject who was vaccinated with TWINRIX, GlaxoSmithKline.  A physician or other health care professional has not verified this report.  The subject's medical history included hepatitis A and typhoid.  Concurrent medical conditions included epilepsy.  Concurrent medications included Levetiracetam (Keppra).  On an unspecified date the subject received 1st dose, 2nd dose of TWINRIX and on 11 December 2007 at 09:00 the subject received 3rd dose of TWINRIX (1 ml, left arm).  At an unspecified time after vaccination with the first and second dose of TWINRIX, the subject experienced tiredness.  On 11 December 2007 in the early afternoon following vaccination with the third dose of TWINRIX, the subject experienced soreness all over and in the evening she experienced tiredness.  In the morning of 12 December 2007, one day after vaccination with TWINRIX, she experienced cheeks that were beet red, fever, tingling from waist down, tingling on her cheeks, two episodes of diarrhea and increased thirst.  She also reported that she has been so tired that she was unable to get out of bed.  The reporter noted that the soreness, tiredness, tingling from the waist down and tingling on her cheeks improved.  The diarrhea and the beet red cheeks resolved.  The tiredness that she experienced following the first two doses also resolved in a couple of days.  At the time of reporting the outcome of the fever, increased thirst and inability to get out of bed were unspecified.
PT r/t clinic 9/15/06 for PPD reading mom states she noticed red, raised, warm to touch on right arm. Applying cool compresses and Tylenol per mom. 9/15/06 Benadryl given instructed to give Q6 hours x 24 hours.
No trouble with right arm. Can not move it; vomiting; Pain in stomach; pain in right arm that went from tip of finger to shoulder down my spin; pain in right arm that went from tip of finger to shoulder down my spin; pain in right arm that went from tip of finger to shoulder down my spin; Can't eat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 12Apr2021 09:30 (Batch/Lot number: unknown) at the age of 60 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Had a sinus infection after last shot" (unspecified if ongoing); "Penicillin" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: covid-19 prior vaccination. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, Product=COVID 19 , Brand =Pfizer, Lot unknown= False, Administration date=15Mar2021, Administration time=11:00 AM, Vaccine location=Left arm), administration date: 15Mar2021, when the patient was 60 years old, for Covid-19 Immunisation. The following information was reported: VACCINATION SITE MOVEMENT IMPAIRMENT (non-serious) with onset 12Apr2021 16:00, outcome "not recovered", described as "No trouble with right arm. Can not move it"; VOMITING (non-serious) with onset 12Apr2021 16:00, outcome "not recovered", described as "vomiting"; ABDOMINAL PAIN UPPER (non-serious) with onset 12Apr2021 16:00, outcome "not recovered", described as "Pain in stomach"; PAIN IN EXTREMITY (non-serious), SPINAL PAIN (non-serious), PAIN (non-serious) all with onset 12Apr2021 16:00, outcome "not recovered" and all described as "pain in right arm that went from tip of finger to shoulder down my spin"; FEEDING DISORDER (non-serious) with onset 12Apr2021 16:00, outcome "not recovered", described as "Can't eat". The events "no trouble with right arm. can not move it", "vomiting", "pain in stomach", "pain in right arm that went from tip of finger to shoulder down my spin", "pain in right arm that went from tip of finger to shoulder down my spin", "pain in right arm that went from tip of finger to shoulder down my spin" and "can't eat" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of vaccination site movement impairment, vomiting, abdominal pain upper, pain in extremity, spinal pain, pain, feeding disorder.  Additional information: No other vaccine in four weeks. The patient was not tested for covid-19 post vaccination. Patient went to doctor they told the patient they never heard of what patient was telling them. Patient stated she didn't have any issues with this arm before shot. Doctor said it's not near shot. It's not red or swollen.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I've had very vivid dreams since my 1st Moderna dose. There is no information regarding this side effect and guidance on when it will go away. This is very concerning to me because this is a new vaccine.
Pt had SOB and Heart racing. BP 116/76, P 88, SaO2 100%, Pt said he felt better and was released to parent
worsening cough, exertional dyspnea and fatigue  + COVID 19 test
Headaches, tingling in mouth, bones "felt achey" about 45 minutes after receiving injection.
Fever, vomiting (symptoms lasted less than a day) with leg swelling. Treatment-Fever resolved 8-25-17 at 10am and was able to keep down food. TYLENOL or ibuprofen as needed per pain, and if not feeling better to let us know and to go to ER.
crying inconsolably for two days followed by lethargy for 1 day;pt was clinically fine;normal exam 2JAN99;
This is a prospective pregnancy case. This 40-year-old female subject was enrolled in a study. The subject received flu seasonal QIV .5 ml on 23rd September 2014. On an unknown date, an unknown time after receiving flu seasonal QIV the subject developed vaccine exposure during pregnancy (non-serious). The outcome of vaccine exposure during pregnancy was unknown. The pregnancy was ongoing. Additional information received on 23 September 2014: The due date was unknown. No other adverse events were reported. This is one of the 3 cases reported by the same reporter for the same vaccine. Follow-up information received on 19 January 2015: The last menstrual period and the number of previous foetuses were also unknown.
Arms started to ache, then body aches, HA's to nausea, recovered within 24 hrs.
Lethargy onset approximately 4 hours after dose.  SOB while supine.  1 day later continued lethargy and orthopnea, plus imms site soreness.
Left wrist joint ached; Left thumb swolled; This is a spontaneous report from a Pfizer sponsored program via contactable male consumer (the patient).  A male patient of unspecified age received first dose of bnt162b2 (Pfizer covid-19 vaccine, Lot number EM9810 and Expiration date not reported), via intramuscular route at Arm Left on 05Feb2021 at 10:30 at SINGLE DOSE for covid-19 immunization. The patient medical history includes type 2nd diabetic years ago, high blood pressure years ago, two back surgeries (in unknown date 1993 and 2016) both were laminectomy, Knee surgery 15plus years ago (arthoscopic) and had shoulder surgery on 05Nov2020 which was repair of rotator cuffs. Prior to shoulder surgery on 05Aug2020 patient had COVID-19 test result was negative. The concomitant medications were not reported. The patient had no known allergies. On 05Feb2021 at 04:00, after 6-7 hours, the patient experienced left wrist joint ahead and, left thumb swelled. The patient received second dose bnt162b2 (Pfizer covid-19 vaccine, Lot number EN6198 and Expiration date not reported), via intramuscular route at Arm Left on 26Feb2021 at 10:30 at SINGLE DOSE for covid-19 immunization. The patient was treated with Tylenol. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.  Follow-up (17May2021): The initial case was missing the following minimum criteria: identifiable patient. Upon receipt of follow-up information on 10Feb2021, this case now contains all required information to be considered valid.  No follow-up attempts are needed. No further information is expected.
patient came in wanting meningitis. vaccination was entered for mmr, and patient received mmr.
Patient states he had 12 weeks of pain from injection site.  Pain did lessen in severity over time.
I received my first dose of Pfizer on 2/26/2021 at 10:30AM. When I woke up on 2/27/2021 at 7:00AM, I noticed that my left foot and ankle area was still and painful. It was so painful that it impacted my ability to walk and do normal activities. The pain lasted for about 6 days. On 3/3/2021, I saw the Doctor employed by my company's insurer, and she drew a blood sample. On 3/4/2021, she informed me that my creatine kinase levels were elevated and suggested I see Doctor who I have been seeing ever since. On 3/5/2021, I saw the Doctor by this time, I was still in pain, though the pain was now less intense than it was before. Doctor suggested that the elevated creatine kinase levels and pain could be an autoimmune response to the Pfizer vaccine, and he asked me to come back on 4/2/2021 for more blood tests. When I returned on 4/2/2021, my creatine kinase levels were within normal range. Between March and July 2021, I had two other instances in which the same pain returned to the same area. I don't recall the dates, but each time, the pain lasted for about 3 days. The pain was due to any physical activity.
This spontaneous report as received from a pharmacist via field representative refers to multiple unspecified patients of unknown age and unknown gender. The pharmacist reported that she had read an unspecified article which stated that multiple unspecified patients had developed autism after receiving MMR II before the age of 36 months. The outcome of the event was unknown. The causality of the events with MMR II was not reported. Additional information has been requested.
Itching, hives and pain around injection site. Pain in injected muscle. Pain in shoulder joint. Heat and redness around injection area. Finally, nausea and arm pain. Nausea may be unrelated to vaccination.
This spontaneous report was received from a physician and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot # L025738, expiration date 14-AUG-2017; lot # L039660, expiration date 04-FEB-2018; lot # L045117, expiration date 06-OCT-2018, lot # M000442, expiration date 31-MAR-2018 (dose and route of administration were not reported). None of the patients reported adverse effects. Administered doses of vaccine experienced a temperature excursion of 32.4 degrees Fahrenheit for 3 hours 30 minutes. This is one of several reports received from the same reporter. Additional information has been requested.
Pt was ordered to receive HPV and Men B. Pt was given HPV and Menquadfi. Pt did not experience any adverse reaction or have any symptoms of a reaction
7 Hours after receiving vaccine patient developed chills, T101 , sweats and hives on both arms and head . Took benedryl, saw Medical Doctor  48hours later.
A non-serious spontaneous report of received expired FLUMIST was received from a health professional concerning an eight-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 20-Nov-2011. The patient received the expired FLUMIST on 23-Nov-2011. The patient was given repeat dose. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. The reporter stated that the patient did not experience any late occurring adverse events.
No adverse event; patient received first moderna dose on 04-MAR-2021 and second dose on 26-SEP-2021; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received first moderna dose on 04-MAR-2021 and second dose on 26-SEP-2021) and NO ADVERSE EVENT (No adverse event) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A, 021821A, 012H21B and 056A22A) for COVID-19 prophylaxis.     The patient's past medical history included High cholesterol. Concurrent medical conditions included Drug allergy (Unspecified drug). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) from an unknown date to 30-Nov-2022 for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received first moderna dose on 04-MAR-2021 and second dose on 26-SEP-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received first moderna dose on 04-MAR-2021 and second dose on 26-SEP-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            On 24-Sep-2022, Patient received fifth dose of Moderna COVID-19 Vaccine (unknown route) in left arm and batch number was A57145B.  On 30-Nov-2022, patient received Paxlovid medication with last administration date on 01-Dec-2022 for treatment of COVID-19.  On 30-Nov-2022, patient experienced nausea and acid reflux. It dramatically improved if patient ate a meal before patient took the medication and if patient sat upright for at least 45 minutes after taking the medication.   It was reported patient started taking Paxlovid the 2nd day of Covid symptoms. 2 days after taking Paxlovid patient tested negative. 4 days after taking Paxlovid patient developed symptoms again. Patient had a runny nose, congestion, low grade fever, and headache. patient tested positive. patient still had symptoms and patient still testing positive. It was 7 days after finishing Paxlovid. It was 12 days after developing symptoms.   No treatment medications were reported.
Received both Flu Vaccine and Moderna Booster shot in Left Arm at around 1:10pm. Felt ok with slight dull headache around  7pm. Had half-cup of coffee to wait for Trick-or-Treaters.  Went to sleep around 10am. Injection site paining. Woke up 2am woth chest pain and cannot breathe deeply. Continued to toss and turn throughout the night with shallow breathing and chest pain rest of the night where I was clutching my chest.  Chest Pain lesser as of morning 7am and can breathe deeper than last night.
angioedema; Face itching; feel unwell; my face was swelling, dark red; my face was swelling, dark red/Palms of both hands were swelling and dark red/feet turning red; Palms of both hands were swelling and dark red.; Wheezing; This is a spontaneous report from a contactable nurse (patient). A 72-year-old female patient (Not pregnant at the time of vaccination) received first dose of bnt162b2 (Batch/Lot Number: EN6198), via an unspecified route of administration in left arm on 03Mar2021 10:45 as single dose for covid-19 immunization. Relevant medical history included: Heart disease, HTN (hypertension), asthma, hereditary factor X deficiency, breast cancer 5 years ago all from an unknown date and unknown if ongoing. The patient was allergies to Lisinopril and povidone-iodine (BETADINE). The patient's concomitant medications were not reported. The patient experienced angioedema, face itching, feel unwell, face was swelling, dark red, dark red/palms of both hands were swelling and dark red/feet turning red, palms of both hands were swelling and dark red, wheezing on 05Mar2021 17:00. The patient felt fine on the 1st and 2nd day post vaccination. Thrilled to finally get 1st dose Pfizer. On 05Mar2021, she began to feel unwell. She looked in mirror, her face was swelling, dark red. Palms of both hands were swelling and dark red. Also feet turning red. Wheezing. Face itching. She was a retired nurse and she knew this was angioedema. Her husband drove her to ED (emergency department). She was given methylprednisolone sodium succinate (SOLUMEDROL) IM and prescription for prednisone. The outcome of events was not resolved. The events resulted in emergency room/department or urgent care. Treatment included: IM methylprednisolone sodium succinate (SOLUMEDROL) in ED and oral prednisone for 3 days. Facility where the most recent COVID-19 vaccine was administered: Public Health Clinic The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, has the patient hasn't been tested for COVID-19.; Sender's Comments: Based on temporal association and known drug profile, a contributory role of the suspect drug cannot be excluded in the development of the reported events. Relevant medical history includes allergies to lisinopril and betadine, which suggests potential for drug allergies. This case will be reassessed upon receipt of additional information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Pt had a fever of 102 and parents noted left pupil dilated greater than right on and off. Evaluated in ER no pupil diff seen bld Cx.
During night awoke to have 2 bouts of watery diarrhea. None during the day. During the day after the vaccine, experienced tiredness,  muscle pains in  both arms, mild headache, sharp pain above left eye (only if closed) ,  felt overheated for a short time, then chilled. Did not take my temperature.